Prestige Consumer Healthcare Inc. $PBH Shares Purchased by Intech Investment Management LLC

Intech Investment Management LLC increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 18.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,307 shares of the company’s stock after purchasing an additional 4,343 shares during the period. Intech Investment Management LLC owned 0.06% of Prestige Consumer Healthcare worth $2,348,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Cerity Partners LLC boosted its position in shares of Prestige Consumer Healthcare by 3.7% in the first quarter. Cerity Partners LLC now owns 3,666 shares of the company’s stock worth $315,000 after acquiring an additional 132 shares during the last quarter. KBC Group NV boosted its position in shares of Prestige Consumer Healthcare by 7.4% in the first quarter. KBC Group NV now owns 2,199 shares of the company’s stock worth $189,000 after acquiring an additional 151 shares during the last quarter. McIlrath & Eck LLC boosted its position in shares of Prestige Consumer Healthcare by 19.1% in the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company’s stock worth $75,000 after acquiring an additional 154 shares during the last quarter. Xponance Inc. boosted its position in shares of Prestige Consumer Healthcare by 5.5% in the first quarter. Xponance Inc. now owns 3,766 shares of the company’s stock worth $324,000 after acquiring an additional 196 shares during the last quarter. Finally, Resona Asset Management Co. Ltd. boosted its position in shares of Prestige Consumer Healthcare by 2.3% in the first quarter. Resona Asset Management Co. Ltd. now owns 9,105 shares of the company’s stock worth $783,000 after acquiring an additional 203 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

Shares of PBH opened at $62.99 on Tuesday. The firm has a 50-day moving average price of $70.22 and a 200 day moving average price of $79.00. The firm has a market capitalization of $3.10 billion, a PE ratio of 14.79, a P/E/G ratio of 2.00 and a beta of 0.46. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. Prestige Consumer Healthcare Inc. has a 52-week low of $61.93 and a 52-week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The company had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. During the same quarter in the prior year, the company earned $0.90 EPS. The business’s quarterly revenue was down 6.6% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. On average, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Zacks Research cut shares of Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research report on Thursday, September 4th. Wall Street Zen cut shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Finally, Canaccord Genuity Group reduced their target price on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.